Pfizer BioNTech Children's COVID-19 Vaccine Trials Show Promising Antibody Boost

Pfizer and BioNTech announced promising results from its COVID-19 vaccine clinical trials in children, showing it was safe and that kids ages 5 to 11 saw a boost in antibodies after receiving the jab. Dr. Amesh Adalja, an infectious disease specialist, joined Cheddar to provide some more details about the highly anticipated announcement. "For children to get their lives back, vaccination is going to be essential, and hopefully more people will get vaccinated, which will also then decrease the ability of this virus to spread as easily as it does in the United States," he said. The results still need to go through the FDA's approval process.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.